上海贝岭(600171) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥394,623,864.96, representing a decrease of 11.61% compared to the same period last year[4]. - The net profit attributable to shareholders was ¥32,826,290.32, down 77.21% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥26,629,887.86, a decrease of 71.27% compared to the previous year[4]. - The basic earnings per share for the period was ¥0.046, reflecting a decline of 77.23% year-on-year[4]. - The decline in net profit was primarily due to weak semiconductor demand and inventory adjustments by major customers, leading to reduced sales scale and gross margin[8]. - Total operating revenue for Q1 2023 was CNY 394.62 million, a decrease of 11.6% compared to CNY 446.43 million in Q1 2022[18]. - Net profit for Q1 2023 was CNY 32.83 million, down 77.3% from CNY 144.62 million in Q1 2022[20]. - The company reported a decrease in total profit to CNY 32.04 million in Q1 2023, down 79.6% from CNY 157.25 million in Q1 2022[19]. Cash Flow and Assets - The company reported a net cash flow from operating activities of -¥98,355,392.61, which is not applicable for year-on-year comparison[4]. - Cash flow from operating activities showed a net outflow of CNY 98.36 million in Q1 2023, compared to a net outflow of CNY 92.23 million in Q1 2022[21]. - Cash and cash equivalents at the end of Q1 2023 were CNY 408.72 million, down from CNY 614.67 million at the end of Q1 2022[22]. - The company's cash and cash equivalents decreased to CNY 694,101,359.15 from CNY 731,362,603.42, reflecting a decline of approximately 5.1%[13]. - As of March 31, 2023, the company's total assets amounted to CNY 4,967,960,154.88, a slight decrease from CNY 4,976,015,882.52 as of December 31, 2022[13]. Expenses and Liabilities - Total operating costs increased to CNY 376.97 million in Q1 2023, up 6.5% from CNY 353.77 million in Q1 2022[19]. - R&D expenses increased during the period, contributing to the decline in profitability[8]. - R&D expenses rose significantly to CNY 73.66 million, an increase of 57.7% compared to CNY 46.67 million in the same period last year[19]. - Total current liabilities decreased to CNY 523,119,427.69 from CNY 581,908,188.36, a decline of about 10.1%[15]. - The company’s non-current liabilities increased slightly to CNY 173,238,576.59 from CNY 166,912,154.11, marking an increase of about 3.9%[15]. Equity and Retained Earnings - The company's total equity increased to CNY 4,271,602,150.60 from CNY 4,227,195,540.05, reflecting a growth of approximately 1.05%[15]. - The company’s retained earnings rose to CNY 2,279,708,657.00 from CNY 2,246,882,366.68, an increase of approximately 1.5%[15]. Government Support and Future Plans - The company received government subsidies amounting to ¥1,296,936.98, which were closely related to its normal business operations[7]. - The company plans to continue focusing on R&D and market expansion despite the current financial challenges[20].